Recent trends in the management of life-threatening ventricular arrhythmias.
An edited summary of an Interdepartmental Conference arranged by the Department of Medicine, UCLA School of Medicine, Los Angeles. William M. Pardridge, MD, Associate Professor of Medicine, is Director of Conferences. This study was supported in part by grants from the Public Health Service; the National Institutes of Health (HL-23970, 1978-1981); the Medical Research Service of the Veterans Administration, and the American Heart Association, the Greater Los Angeles Affiliate.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D004594:Electrophysiology; D006321:Heart / Q000503:physiopathology; D006323:Heart Arrest / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D010138:Pacemaker, Artificial; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000601:surgery
D000889:Anti-Arrhythmia Agents